Skip to main content
Caplight Logo









Discure Technologies

Discure Technologies

Private
IsraelHealthcare & Life Scienceshttps://discuremd.com/

Last Round

Seed

Mar 1, 2022

Total Funding Raised

$5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Discure Technologies is a medical technology company that develops a minimally invasive, implantable bioelectronic device designed to treat and reverse degenerative disc disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationchronic pain managementmedical devicebioelectronicsnon-invasive therapynerve stimulationpain techclinical-stagechronic low back paindrug-free pain reliefFDA breakthrough devicemedtechclinical trialspain management clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Discure Technologies Comparables

Compare Discure Technologies with similar companies based on industry and business-model similarity.

Discure Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioWave Corporation
76%
SPR Therapeutics
73%
Globus Medical
70%

Discure Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2022

Key People

Founding team and executive leadership

Yuval Mandelbaum

Chief Executive Officer

Executive Team

Yehuda Zadok

Chief Technology Officer

Executive Team

Yossi Cohen

Chief Financial Officer

Executive Team

Discure Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 248% MoM.

Discure Technologies Filings

Explore SEC and related filing metadata, where available.

Discure Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Discure Technologies's valuation, stock price, and market status.

Is Discure Technologies a public or private company?

Discure Technologies is a private company.

What is the current stock price of Discure Technologies?

Discure Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is Discure Technologies worth (valuation)?

Valuation information for Discure Technologies is not publicly available.

Can I buy Discure Technologies stock?

Discure Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Discure Technologies's last funding round?

Discure Technologies's most recent funding round was Seed on March 1, 2022.

Who are the main investors in Discure Technologies?

Key investors in Discure Technologies include Rainbow Medical.

Will Discure Technologies IPO soon?

No public IPO plans have been announced for Discure Technologies.

How can I track Discure Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Discure Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range12
Year Founded2019
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?